Edwards Files Response To CMS
Edwards Lifesciences (NYSE:EW), a major player in the field of heart valves, has filed its official response to the Centers for Medicare & Medicaid Services (CMS) on the proposed National Coverage Determination (“NCD”) for Transcatheter Aortic Valve Replacement (“TAVR”). In February this year, CMS had published a decision memo specifying the circumstances under which coverage [...]
Edwards Lifesciences (NYSE:EW), a major player in the field of heart valves, has filed its official response to the Centers for Medicare & Medicaid Services (CMS) on the proposed National Coverage Determination (“NCD”) for Transcatheter Aortic Valve Replacement (“TAVR”). In February this year, CMS had published a decision memo specifying the circumstances under which coverage should be provided.
Earlier, in September 2011, the CMS had decided to initiate the NCD process. This … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards